These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6805199)
21. [Use of Fe59 and Cr51 for the evaluation of certain parameters of erythropoiesis]. Lapchenkov VI; Korytov SP; Kanaev SV Med Radiol (Mosk); 1973 Oct; 18(10):60-3. PubMed ID: 4524495 [No Abstract] [Full Text] [Related]
22. [How do we optimally evaluate iron stores in dialyzed patients treated with erythropoiesis stimulating agent?]. Kessler M; Salignac S; Aimone-Gastin I Nephrol Ther; 2006 Sep; 2 Suppl 4():S261-5. PubMed ID: 17373268 [TBL] [Abstract][Full Text] [Related]
23. Serum ferritin, iron and transferrin in women with thyrotoxic Graves' disease before and after methimazole treatment. Zwirska-Korczala K; Buntner B; Sobieraj H; Ostrowska Z; Kniazewski B; Swietochowska E Acta Physiol Pol; 1990; 41(7):163-8. PubMed ID: 2136311 [TBL] [Abstract][Full Text] [Related]
24. A solid phase radioimmunoassay method for ferritin in serum using (125)I-labelled ferritin. Wide L; Birgegård G Ups J Med Sci; 1977; 82(1):15-9. PubMed ID: 20078269 [TBL] [Abstract][Full Text] [Related]
25. Role of serum ferritin in assessment of disease activity in acute & chronic leukemia. Ahlawat S; Bhargava M; Arya LS; Kochupillai V; Kumar R Indian J Med Res; 1994 Aug; 100():66-9. PubMed ID: 7927558 [TBL] [Abstract][Full Text] [Related]
26. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease. Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268 [TBL] [Abstract][Full Text] [Related]
27. [Hypoferraemia and serum ferritin (author's transl)]. Wohlenberg H; Panitz N; Wacheck W Dtsch Med Wochenschr; 1980 Oct; 105(44):1527-30. PubMed ID: 7428660 [TBL] [Abstract][Full Text] [Related]
28. [Clinical value of serum ferritin determination in the diagnosis of iron deficiency disease]. Bernát SI; Nemet K Orv Hetil; 1984 Jan; 125(1):23-26. PubMed ID: 6691023 [No Abstract] [Full Text] [Related]
29. Serum ferritin, iron levels and iron binding capacity in asymmetric SGA babies. Karaduman D; Ergin H; Kiliç I Turk J Pediatr; 2001; 43(2):121-4. PubMed ID: 11432489 [TBL] [Abstract][Full Text] [Related]
30. [Serum ferritin levels in patients with chronic uremia]. Schmelczer M; Burger T; Gofman L; Karátson A; Molnár L Orv Hetil; 1986 May; 127(20):1191-3. PubMed ID: 3714262 [No Abstract] [Full Text] [Related]
31. [Study of functional state of erythropoiesis by means of parenterally administered radioactive iron in patients with acute and chronic leukemia]. Mendeleev IM Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):7-12. PubMed ID: 5259266 [No Abstract] [Full Text] [Related]
32. [Serum ferritin and cytochemical storage iron in erythropoiesis and the R.E.S. in iron deficiency and faulty iron metabolism]. Fereberger W; Neubauer M; Leb G Acta Med Austriaca Suppl; 1979; 6():366-8. PubMed ID: 299235 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of iron deposits in blood donors by determining serum ferritin using radioimmunoassay]. Cordovilla JJ; de la Fuente C; Llorens V; Pastor JM; Hermosa V; Carril JM Rev Clin Esp; 1987 Jun; 181(2):75-8. PubMed ID: 3628903 [No Abstract] [Full Text] [Related]
34. [Clinical evaluation of serum ferritin-iron ratio in the diagnosis of malignant diseases (author's transl)]. Yoshii M; Kohsaka T; Nakajima K; Morita R; Torizuka K Kaku Igaku; 1980 Apr; 17(3):317-23. PubMed ID: 6156257 [No Abstract] [Full Text] [Related]
35. Evaluation of erythropoiesis by serum transferrin receptor and ferritin in infants aged 0-6 months. Ulukol B; Tezcan S; Akar N; Gökçe H; Cin S Pediatr Hematol Oncol; 2004 Jun; 21(4):293-305. PubMed ID: 15205091 [TBL] [Abstract][Full Text] [Related]
36. Erythropoiesis in rats with acute myelogenous leukemia. Handler EE; Handler ES J Reticuloendothel Soc; 1970 Mar; 7(3):328-37. PubMed ID: 5265691 [No Abstract] [Full Text] [Related]
37. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload. Kim IH; Moon JH; Lim SN; Sohn SK; Kim HG; Lee GW; Kim YS; Lee HS; Kwon KY; Kim SH; Park KT; Chung JS; Lee WS; Lee SM; Hyun MS; Kim H; Ryoo HM; Bae SH; Joo YD Transfusion; 2015 Jul; 55(7):1613-20. PubMed ID: 25764017 [TBL] [Abstract][Full Text] [Related]
38. An evaluation of serum ferritin determination in chronic hemodialysis patients with persistent low serum iron concentration. Iseki K; Fujimi S; Onoyama K; Fujishima M Miner Electrolyte Metab; 1988; 14(5):257-61. PubMed ID: 3173263 [TBL] [Abstract][Full Text] [Related]
39. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181 [TBL] [Abstract][Full Text] [Related]
40. [Changes in the biochemical indices in iron-deficiency erythropoiesis]. Gekova K; Georgieva B; Arsov Ts; Decheva Z; Peĭchev D Vutr Boles; 1989; 28(2):77-80. PubMed ID: 2763526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]